“Tirzepatide improves obstructive sleep apnoea in people with obesity.”
Verdict on this exact wording — not on the compound overall, and not on whether use is advisable.
Supported — in the randomised trial populations studied.
- Dedicated randomised trials reported reduced apnoea severity.
- Effects are tied to the studied populations and treatment durations.
- This is a good example of a claim moving from 'promising' to 'supported' because someone ran the trial.